The Comparative Efficacy of Standard Treatment Plus Ribavirin vs Standard Treatment Alone in Preventing Clinically Significant Hemorrhage in Patients With Dengue Fever

Clinical trial NCT06744777 · COMPLETED

Trial details

NCT number: NCT06744777
Sponsor: Khyber Medical University Peshawar
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Dengue Fever Dengue Hemorrhagic Fever Severe Dengue

Start date: 2024-12-17
Primary completion: 2025-04-28
Enrollment: 284

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.